These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1767964)

  • 1. [A possible complication of therapeutic plasmapheresis].
    Shafro LI; Tsimermane GI; Krivulis DB; Andreev GN
    Anesteziol Reanimatol; 1991; (5):52-3. PubMed ID: 1767964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate-induced impairment of neuromuscular transmission in human and experimental autoimmune myasthenia gravis.
    Wirguin I; Brenner T; Shinar E; Argov Z
    Ann Neurol; 1990 Mar; 27(3):328-30. PubMed ID: 2158269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the side effects of therapeutic cytapheresis and those of other types of hemapheresis.
    Rossi PL; Cecchini L; Menichella G; De Rosa G; Alfano G; Pierelli L; Testa A; Candido A; Vittori M; Mango G
    Haematologica; 1991 Mar; 76 Suppl 1():75-80. PubMed ID: 1650743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications and adverse effects of plasmapheresis and their incidences].
    Yuasa S
    Nihon Rinsho; 1984 Aug; 42(8):1920-9. PubMed ID: 6392614
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intensive plasmapheresis--possible difficulties and complications].
    Ryzhko VV; Gorodetskií VM; Borisov BA
    Ter Arkh; 1987; 59(6):70-5. PubMed ID: 3629503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications with plasmapheresis].
    Shibuya N; Fujishita S
    Nihon Rinsho; 1991 Dec; 49 Suppl():567-71. PubMed ID: 1808318
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic alkalosis due to plasmapheresis.
    Pearl RG; Rosenthal MH
    Am J Med; 1985 Sep; 79(3):391-3. PubMed ID: 3929603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic alkalosis induced by plasmapheresis in a patient with systemic lupus erythematosus.
    Choi MY; Lee JD; Lee SH; Park IS; Woo JY; Choi EJ; Chang YS; Bang BK
    J Korean Med Sci; 1993 Jun; 8(3):207-9. PubMed ID: 8240751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in calcium distribution during therapeutic plasmapheresis.
    Roberts WH; Domen RE; Walters MI
    Arch Pathol Lab Med; 1984 Nov; 108(11):881-3. PubMed ID: 6548363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluid.
    Weinstein R
    J Clin Apher; 1996; 11(4):204-10. PubMed ID: 8986866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benefits and side effects of preoperative autologous blood donation in 11 heart surgery patients].
    Walpoth BH; Volken U; Aeschbacher B; Roth F; Althaus U; Nydegger U
    Schweiz Med Wochenschr; 1991 Sep; 121(38):1365-71. PubMed ID: 1925466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regional anticoagulation with sodium citrate: chronic utilization in the hemodialysis patient].
    Collart F; Wens R; Dratwa M
    Nephrologie; 1993; 14(3):151-4. PubMed ID: 8367007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Citrate (CG-120) therapy for urolithiasis. 1. Clinical effects].
    Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
    Hinyokika Kiyo; 1988 May; 34(5):905-17. PubMed ID: 3051945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of oral or intravenous citrate on the activation of neutrophils in vitro.
    Pfister RR; Haddox JL; Pfister DR; Lank KM; Snyder TL
    Cornea; 1988; 7(4):244-51. PubMed ID: 3219858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methodology of regional blood stabilization with sodium citrate during hemosorption and the first experience of its clinical application].
    Egorov VM; Nazarov AV; Sentsov VG; Sukhanov VA; Ignatenko TV; Rokin SR; Amon EP
    Anesteziol Reanimatol; 1991; (6):40-2. PubMed ID: 1789484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased ionized calcium during therapeutic plasma exchange pheresis and platelet pheresis.
    Morse EE; Hohnadel DC; Genco P; Katz AJ
    Johns Hopkins Med J; 1980 Jun; 146(6):260-3. PubMed ID: 7382251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory and clinical effects of the infusion of ACD solution during plateletpheresis.
    Olson PR; Cox C; McCullough J
    Vox Sang; 1977 Aug; 33(2):79-87. PubMed ID: 883248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.